y 27632 has been researched along with mitotempo in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (mitotempo) | Trials (mitotempo) | Recent Studies (post-2010) (mitotempo) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 100 | 0 | 99 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, R; Han, J; Hu, Z; Ma, X; Zhao, D | 1 |
1 other study(ies) available for y 27632 and mitotempo
Article | Year |
---|---|
Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
Topics: Alanine Transaminase; Amides; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Cyclooxygenase 2; DNA-Binding Proteins; Endotoxemia; Female; Hepatocytes; High Mobility Group Proteins; Lipopolysaccharides; Liver; Liver Diseases; Male; Malondialdehyde; Mice, Inbred C57BL; Mitochondria; Organophosphorus Compounds; Peroxidase; Piperidines; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Superoxide Dismutase | 2016 |